Optimal Platelet Dose Strategy for Management of Thrombocytopenia

Clinical trial NCT00128713 · COMPLETED

Trial details

NCT number: NCT00128713
Sponsor: Carelon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombocytopenia

Start date: 2004-07-01
Primary completion: 2008-01-01
Enrollment: 1351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.